The project aims to unravel the complex molecular landscape governing conditions like optic neuropathies, and retinal degenerative diseases, causing progressive vision loss and irreversible blindness. This research seeks to identify genetic determinants, molecular pathways, and potential targets for therapeutic interventions in NVSD. By exploring shared and distinct mechanisms across different conditions, it aims to develop precise interventions to prevent or delay vision loss.
Our plan is to dive deep into both rare and common genomic alterations among patients. We’ll use advanced bioinformatics method to integrate genomics, transcriptomics, and proteomics data from ocular and brain tissues in order to identify associated pathways and characterize underlying molecular mechanisms.
This research has potential to enhance diagnosis and prognosis, raise awareness, and empower individuals to make informed eye health choices. Ultimately, it could reduce the socioeconomic impact of vision impairment, addressing public interest in preserving vision and improving quality of life.
